Daniel Steblow

Title: Daniel Steblow: Innovator in Antiviral Research

Introduction

Daniel Steblow is a notable inventor based in Banks, Oregon. He has made significant contributions to the field of antiviral research, particularly through his innovative work on 2-pyrimidone compounds. His research focuses on developing potent antiviral agents against Alphaviruses, which are responsible for various viral infections.

Latest Patents

Daniel Steblow holds 1 patent for his invention titled "2-pyrimidone analogs as potent antiviral agents against Alphaviruses." This patent addresses the use of 2-pyrimidone compounds that can inhibit viral infections. The methods described in his patent are aimed at treating infections caused by Alphaviruses, including chikungunya, Eastern equine encephalitis, Western equine encephalitis, and Venezuelan equine encephalitis. The abstract of the patent serves as a scanning tool for searching within this specific area of research.

Career Highlights

Throughout his career, Daniel has worked with reputable organizations such as Southern Research Institute and Oregon Health & Science University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Daniel has collaborated with esteemed colleagues, including Ashish Kumar Pathak and Corinne E Augelli-Szafran. These partnerships have further enriched his research endeavors and have led to significant advancements in antiviral therapies.

Conclusion

Daniel Steblow's work in developing antiviral agents showcases his commitment to addressing viral infections and improving public health. His innovative research continues to pave the way for future advancements in the field of virology.